Arteris, Inc. (AIP) Stock Price & How to Invest
Short answer
AIP is Arteris, Inc., a semiconductor system IP company that licenses network-on-chip (NoC) interconnect technology used to wire together the blocks inside AI, automotive, and data-center chips. You can buy shares or fractional shares at any major broker, hold it through a small-cap or semiconductor ETF, or treat it as one holding in a thematic AI-infrastructure basket.
AIP stock price
As of 2026-07-01, Arteris, Inc. (AIP) last closed at $43.81, up 382.0% over the past year. Over the past 52 weeks it has traded between $8.59 and $48.59.
Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or Arteris, Inc.'s investor relations page. Walnut is informational, not investment advice.
What does Arteris, Inc. (AIP) do?
Arteris sells the plumbing that connects the pieces of a modern chip. Its network-on-chip (NoC) interconnect IP, sold under names like FlexNoC, Ncore, and the newer FlexGen, sits between the CPU, GPU, memory, and accelerator blocks on a system-on-chip and manages how data moves between them. Chip designers license this IP rather than build it themselves, which saves engineering time on increasingly complex designs. Arteris makes money in two layers: up-front and recurring license fees (tracked as annual contract value, or ACV) plus per-unit royalties that accrue every time a customer ships a chip containing its IP. That royalty stream is why the company reports metrics like combined ACV plus royalties (around $92.8 million exiting Q1 2026, up 39% year over year) and remaining performance obligations (about $118 million) alongside GAAP revenue.
Founded in 2003 and headquartered in Campbell, California, Arteris went public on Nasdaq in 2021 under the ticker AIP. Its IP has shipped in more than 4 billion devices, and its customer roster spans large semiconductor and technology names including AMD, NXP, and AI-chip startup Tenstorrent, across automotive, AI and machine learning, enterprise computing, and consumer markets. The AI and chiplet boom has raised demand for exactly the kind of high-bandwidth on-chip connectivity Arteris specializes in, and the 2025 launch of FlexGen (a smart, more automated NoC generator) plus the acquisition of hardware-security firm Cycuity broadened its footprint. The stock rose sharply over the trailing year, which lifted the valuation well ahead of current revenue.
What's driving Arteris, Inc. (AIP)?
1. AI and chiplet demand tailwind
As chips get more complex and shift toward multi-die chiplet designs, the interconnect fabric Arteris licenses becomes harder to build in-house and more valuable. AI accelerators, automotive processors, and data-center silicon all need high-bandwidth on-chip connectivity. This structural demand is the core reason the business has been growing near 40% on its combined contract-plus-royalty metric.
2. Recurring license plus royalty model
Arteris earns up-front and recurring license fees plus per-unit royalties that accrue for years as customers ship products containing its IP. Variable royalties reached roughly $7.9 million in Q1 2026, up about 67% year over year. Because royalties compound off a growing installed base already shipped in over 4 billion devices, past design wins can keep paying out well after the initial contract.
3. New products and blue-chip customers
The 2025 launch of FlexGen, its smart NoC generator, reached over 30 production deployments across 10 customers by year end, and the Cycuity acquisition added hardware-security capability. Named users include AMD, NXP, and Tenstorrent. Each new design win with a large chipmaker seeds a future royalty stream and deepens Arteris' role in customer roadmaps.
4. Path toward profitability
Arteris carries a very high gross margin (around 90%) but still runs operating and net losses as it invests in engineering and sales. Management guided full-year 2026 revenue to roughly $91 to $95 million with positive free cash flow, so the debate is how quickly the high-margin revenue base grows into the cost structure and turns the reported losses into sustained profit.
What are the risks to Arteris, Inc. (AIP)?
Arteris is unprofitable on a GAAP basis and trades at a steep price-to-sales multiple (well above 20x) after the stock rose sharply over the past year, which leaves little room for disappointment. Royalty revenue depends on customers actually shipping chips, so it is exposed to the semiconductor cycle and to design cancellations or delays. The customer base is concentrated among a relatively small number of large chipmakers, and it competes with far larger EDA and IP vendors such as Cadence and Synopsys, plus the risk that big customers build interconnect in-house. Ongoing stock-based compensation dilutes shareholders, and a planned CFO transition in 2026 adds some management-continuity uncertainty.
How is Arteris, Inc. (AIP) valued? (approximate, July 2026)
A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Arteris, Inc.'s investor relations page or your broker.
- Revenue (Q1 2026 quarterly): ~$22.9 million, up ~39% year over year
- ACV plus royalties (exiting Q1 2026): ~$92.8 million, up ~39%
- Full-year 2026 revenue guidance: ~$91 to $95 million, with positive free cash flow
- Net income (trailing): ~negative (net loss; not yet GAAP profitable)
- Price-to-sales ratio: ~27x
- Market cap: ~$2.0 billion (stock ~$47 per share)
Figures are approximate and tied to the asOf date, so verify live numbers before acting. AIP trades on a high price-to-sales multiple with a negative P/E because it is still unprofitable, so traditional earnings multiples do not apply. The valuation prices in continued rapid growth in contracts and royalties, which means the figures matter most as a gauge of how much optimism is already reflected in the stock.
Who competes with Arteris, Inc. (AIP)?
Large EDA and IP vendors
Cadence Design Systems and Synopsys are the dominant chip-design-software and IP companies, and both offer their own network-on-chip and system IP (for example, Cadence's Janus NoC). They have far greater scale, broader tool portfolios, and existing relationships with nearly every chipmaker, making them the most direct competitive threat to Arteris' interconnect franchise.
In-house and alternative interconnect approaches
The largest chip designers can build their own on-chip interconnect fabric rather than license it, and general-purpose IP providers such as Arm offer interconnect technology as part of wider portfolios. This do-it-yourself option caps how much of the market a specialist like Arteris can address, especially among the biggest, best-resourced customers.
Adjacent system-IP and security providers
Arteris also touches SoC-integration software and, via its Cycuity acquisition, hardware security. In these adjacent areas it overlaps with other specialized IP and verification vendors, and competition there influences how much additional revenue Arteris can layer on top of its core NoC business.
How to invest in Arteris, Inc. (AIP)
There are three common ways to get AIP exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic basket, so AIP sits alongside other stocks that express the same thesis.
Walnut takes the basket route. Describe a thesis where AIP fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.
The bottom line on Arteris, Inc. (AIP)
Arteris is a small, fast-growing but still unprofitable IP-licensing business riding the AI and chiplet design wave, trading at a rich price-to-sales multiple after a large run-up, so the central question is whether royalty and contract growth can eventually catch up to the valuation.
More on Arteris, Inc. (AIP)
Whether AIP is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is AIP a buy?, and where the stock could go from here in the AIP stock forecast.
For income investors, whether AIP pays a dividend and how the payout looks is covered in does AIP pay a dividend?
Build a basket around AIP with Walnut
Use Arteris, Inc. as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
What company is AIP?
+
AIP is the Nasdaq ticker for Arteris, Inc., a semiconductor system IP company based in Campbell, California. It licenses network-on-chip (NoC) interconnect and related IP that chip designers use to connect the blocks inside a system-on-chip. Its technology has shipped in more than 4 billion devices across AI, automotive, and consumer markets.
Is AIP a good stock to buy right now?
+
That depends on your goals, time horizon, and risk tolerance, and this is not investment advice. The bull case is rapid growth in contracts and royalties driven by AI and chiplet demand and a very high gross margin. The bear case is that the company is still unprofitable and trades at a rich price-to-sales multiple after a large run-up. Weigh both against your own portfolio.
How does Arteris make money?
+
Arteris earns money in two layers. First, it charges license fees for its network-on-chip and system IP, tracked as annual contract value (ACV). Second, it collects per-unit royalties each time a customer ships a chip containing that IP. The royalty stream compounds over time as more designs reach production, which is why the company reports combined ACV plus royalties alongside revenue.
Does AIP pay a dividend?
+
No. Arteris does not pay a dividend. It is a growth-stage, currently unprofitable company that reinvests in engineering, sales, and acquisitions rather than returning cash to shareholders. Any return from AIP would come from share-price movement rather than income, which matters if you are building a portfolio for current yield.
Why has AIP stock been so volatile?
+
Arteris is a small-cap, unprofitable company whose revenue is tied to the semiconductor design cycle, so its shares tend to swing on earnings, guidance changes, and AI sentiment. The stock rose sharply over the trailing year on AI-driven optimism, which can amplify moves in both directions. High-multiple, small-cap names generally carry more price volatility than large, profitable ones.
Who are Arteris' main competitors?
+
Its most direct competitors are the large chip-design software and IP vendors Cadence Design Systems and Synopsys, both of which offer their own network-on-chip and system IP. Arteris also competes with in-house interconnect development at big chipmakers and with broader IP providers such as Arm. Its specialist focus is both its edge and a limit on the market it can address.
Who are Arteris' customers?
+
Arteris licenses its IP to semiconductor and technology companies across automotive, AI and machine learning, enterprise computing, and consumer markets. Publicly named users include AMD, NXP, and AI-chip startup Tenstorrent. Its newer FlexGen product reached over 30 production deployments across 10 customers by the end of 2025, and its IP has shipped in more than 4 billion devices overall.
What are the main risks of investing in AIP?
+
The main risks are that Arteris is not yet profitable and trades at a high price-to-sales multiple, so expectations are elevated. Royalties depend on customers shipping chips, which ties results to the semiconductor cycle. The customer base is concentrated, competition from much larger vendors like Cadence and Synopsys is intense, and stock-based compensation dilutes shareholders over time.
Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Arteris, Inc.'s investor relations page or your broker before making investment decisions.